# Valproic Acid Sodium Salt in Bipolar Disorder

> **NCT00431522** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 58 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Valproic acid, sodium salt

## Key facts

- **NCT ID:** NCT00431522
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2009-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431522, "Valproic Acid Sodium Salt in Bipolar Disorder". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00431522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*